← Eichor
Condition: Ulcerative Colitis Chronic Moderate Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ulcerative Colitis Chronic Moderate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Combination of Diet and Oral Budesonide for Ulcerative Colitis
NA · 6 location(s) · Wolfson Medical Center · NCT05791487R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1 · 5 location(s) · Rise Therapeutics LLC · NCT05666960An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintena
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03167437Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
Phase N/A · 1 location(s) · University of California, San Diego · NCT06311123A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Phase 2 · 207 location(s) · Eli Lilly and Company · NCT06598943A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn'
Phase 3 · 68 location(s) · Eli Lilly and Company · NCT04844606Study of Novel Therapeutics for Acute Remedy of Colitis
Phase 2 · 2 location(s) · Brigham and Women's Hospital · NCT06420492
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.